* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *A Evans,Rhodri %A Elwyn,Glyn %A Edwards,Adrian %A Watson,Eila %A Austoker,Joan %A Grol,Richard +初级保健和公共卫生系，加的夫大学，neadd Meirionnydd, Heath Park, Cardiff CF14 4YS，威尔士，英国，+44 2920687195，evansr10@cardiff.ac.uk %K现场测试%K患者决策支持技术%K前列腺特异性抗原(PSA) %K前列腺肿瘤%K知情选择%K决策支持技术%K患者教育%K患者参与%K消费者健康信息%K互联网%D 2007 %7 13.7.2007 %9原始论文%J J医学互联网Res %G英文%X背景:正如国际患者决策辅助标准合作组织的共识声明所确定的那样，现场测试是患者决策支持技术(PDSTs)开发中的质量保证标准。我们将现场测试纳入基于网络的前列腺特异性抗原PDST的开发中，称为prodex，它是英国前列腺癌风险管理计划的一部分。目的:本研究的目的是基于prodex的现场测试，为未来PDSTs的现场测试开发一个模型。我们的目标是(1)探索男性对不断发展的prodex原型的反应，(2)评估这些反应对开发过程的影响，以及(3)开发一个基于反应及其对开发过程的影响的PDSTs现场测试模型。方法:在男性家中观看了prodex不断发展的原型后，对他们进行了半结构化访谈。这些人根据所看到的原型被分组。研究人员从英国威尔士不同地区的两个家庭诊所招募了年龄在40至75岁之间的男性。 In the interviews, the men were asked for their views on Prosdex, both as a whole and in relation to specific sections such as the introduction and video clips. Comments and technical issues that arose during the viewings were noted and fed back to the developers in order to produce subsequent prototypes. Results: A total of 27 men were interviewed, in five groups, according to the five prototypes of Prosdex that were developed. The two main themes from the interviews were the responses to the information provided in Prosdex and the responses to specific features of Prosdex. Within these themes, two of the most frequently encountered categories were detail of the information provided and balance between contrasting viewpoints. Criticisms were encountered, particularly with respect to navigation of the site. In addition, we found that participants made little use of the decision-making scale. The introduction of an interactive contents page to prototype 2 was the main change made to Prosdex as a result of the field-testing. Based on our findings, a model for the field-testing of PDSTs was developed, involving an exploratory field-testing stage between the planning stage and the development of the first prototype, and followed by the prototype field-testing stage, leading to the final PDST. Conclusions: In the field-testing of Prosdex, a Web-based prostate-specific antigen PDST, the responses of interviewed men were generally favorable. As a consequence of the responses, an interactive contents page was added to the site. We developed a model for the future field-testing of PDSTs, involving two stages: exploratory field-testing and prototype field-testing. %M 17627930 %R 10.2196/jmir.9.3.e21 %U //www.mybigtv.com/2007/3/e21/ %U https://doi.org/10.2196/jmir.9.3.e21 %U http://www.ncbi.nlm.nih.gov/pubmed/17627930